CNMD: the cashflow

MyFinsight

For the year ending 2025-12-31, CNMD had $16,358K increase in cash & cash equivalents over the period. $150,883K in free cash flow.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-12-31
Net income	47,055
Depreciation	17,143
Amortization of deferred debt issuance costs	5,646
Amortization	57,138
Stock-based compensation	28,323
Deferred income taxes	3,523
Changes in fair value of contingent consideration	22,951
Loss on early extinguishment of debt	363
Accounts receivable	2,361
Inventories	6,733
Accounts payable	-9,749
Income taxes	-558
Accrued compensation and benefits	14,913
Other assets	13,159
Other liabilities	6,194
Net cash provided by operating activities	170,689
Purchases of property, plant and equipment	19,806
Other	1,150
Net cash used in investing activities	-20,956
Payments on term loan	99,821
Proceeds from term loan	25,234
Payments on revolving line of credit	695,432
Proceeds from revolving line of credit	695,432
Payments to redeem convertible notes	0
Payments related to contingent consideration	33,760
Payments related to debt issuance costs	2,897
Dividends paid on common stock	24,746
Other, net	170
Net cash used in financing activities	-135,820
Effect of exchange rate changes on cash and cash equivalents	2,445
Net increase (decrease) in cash and cash equivalents	16,358
Cash and cash equivalents at beginning of period	24,459
Cash and cash equivalents at end of period	40,817

Unit: Thousand (K) dollars